Spermosens are active in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes products for male infertility and individually tailored fertility treatments. Research and development is conducted via its own technological platform that analyzes sperm quality, which is further used for medical data and potential fertilization. The largest operations are in the Nordic market.

Quotes for Spermosens AB (publ)

Right Now

+/-
0.07
%
3,74%
Latest
1.94
High
1.94
Low
1.87
Volume
31 757
Turnover (SEK)
60 498
Market Value (MSEK)
23,5
Time (Latest trade)
2022-11-30 10:40

Board

CEO

  • John Lempert

Chairperson of the Board

  • Eva Nilsagård

Board

  • Christina Östberg Lloyd
  • Ingela Liljeqvist Soltic
  • Kushagr Punyani
  • Sören Melsing Frederiksen

Videos

Largest Owners

Name Capital % Votes % Date
Kushagr Punyani 13,03 13,03 2022-09-28
Avanza Pension 8,81 8,81 2022-09-28
Mohamad Takwa 8,60 8,60 2022-09-28
Nordnet Pensionsförsäkring 4,19 4,19 2022-09-28
Massimiliano Franzé 2,55 2,55 2022-09-28
Sven Rasmusson 2,26 2,26 2022-09-28
Søren Melsing Frederiksen 1,82 1,82 2022-06-28
Philip Rasmusson 1,60 1,60 2022-09-28
Johan Svensson 1,35 1,35 2022-09-28
Darren Glover 1,29 1,29 2022-09-28
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-12-19 Extra bolagsstämma 2022

  • 2023-02-08 Bokslutskommuniké 2022

  • 2023-04-19 Delårsrapport 2023-Q1

  • 2023-07-14 Delårsrapport 2023-Q2

  • 2023-10-13 Delårsrapport 2023-Q3